Metabolic markers associated with insulin resistance predict type 2 diabetes in Koreans with normal blood pressure or prehypertension

BackgroundQuestions remain as to the association between essential hypertension and increased incidence of type 2 diabetes (T2DM). The premise of this analysis is that insulin resistance/compensatory hyperinsulinemia is a major predictor of T2DM, and the greater the prevalence of insulin resistance within any population, normotensive or hypertensive, the more likely T2DM will develop. The hypothesis to be tested is that surrogate estimates of insulin resistance will predict incident T2DM to a significant degree in persons with normal blood pressure or prehypertension.MethodsAnalysis of data from a population-based survey of 10, 038 inhabitants of rural and urban areas of Korea, ≥40 years-old, initiated in 2001, with measures of demographic and metabolic characteristics at baseline and 8-years later. Participants were classified as having normal blood pressure or prehypertension, and three simple manifestations of insulin resistance related to the pathophysiology of T2DM used to predict incident T2DM: (1) glycemia (plasma glucose concentration 2-hour after 75 g oral glucose challenge = 2-hour PG); (2) hyperinsulinemia (plasma insulin concentration 2-hour after 75 g oral glucose challenge = 2-hour PI); and (3) dyslipidemia (ratio of fasting plasma triglyceride/high/density lipoprotein cholesterol concentration = TG/HDL-C ratio).ResultsFully adjusted hazard ratios (HR, 95 % CI) for incident T2DM were highest (P < 0.001) in the quartile of individuals with the highest 2-hour PG concentrations, ranging from 5.84 (3.37–10.1) in women with prehypertension to 12.2 (7.12–21.00) in men with normal blood pressure. T2DM also developed to a significantly greater degree in subjects within the highest quartile of TG/HDL-C ratios, with HRs varying from 2.91 (1.63–2.58) in women with prehypertension (P < 0.001) to 1.77 (1.12–2.81, P < 0.05) in men with prehypertension. The least predictive index of insulin resistance was the 2-hour PI concentration. Subjects with normal blood pressure in the highest quartile of 2-hour PI concentrations were significantly associated with incident T2DM, with HRs of 1.5 (1.02–2.20, P = 0.25) and 2.02 (1.35–3.02, P < 0.001), in men and women, respectively. Finally, incidence of T2DM in the highest quartile was somewhat greater in patients with prehypertension, irrespective of predictor.ConclusionsMetabolic variables associated with insulin resistance (glycemia, insulinemia, and dyslipidemia) predict the development of T2DM in patients with either normal blood pressure or prehypertension.

[1]  S. Anderson,et al.  Usual Blood Pressure and Risk of New-Onset Diabetes , 2015, Journal of the American College of Cardiology.

[2]  P. Weidmann,et al.  Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. , 1991, The American journal of medicine.

[3]  Resistance to insulin-stimulated-glucose uptake in patients with hypertension. , 1987, The Journal of clinical endocrinology and metabolism.

[4]  G. Reaven,et al.  Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high‐density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria , 2013, Journal of internal medicine.

[5]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[6]  D. Mozaffarian,et al.  Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study. , 2013, American journal of epidemiology.

[7]  I. Njølstad,et al.  Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of The Tromsø Study , 2010, European Journal of Epidemiology.

[8]  Hyun-Young Park,et al.  Hypertension is an independent risk factor for type 2 diabetes: the Korean genome and epidemiology study , 2015, Hypertension Research.

[9]  S. Kahn,et al.  Differential Association Between HDL Subclasses and the Development of Type 2 Diabetes in a Prospective Study of Japanese Americans , 2015, Diabetes Care.

[10]  G. Reaven Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[11]  G. Reaven,et al.  Relationship Between the Plasma Insulin Response to Oral Glucose and Insulin-stimulated Glucose Utilization in Normal Subjects , 1984, Diabetes.

[12]  G. Reaven,et al.  Evidence for an independent relationship between insulin resistance and fasting plasma HDL‐cholesterol, triglyceride and insulin concentrations , 1992, Journal of internal medicine.

[13]  G. Reaven,et al.  Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. , 2012, The American journal of cardiology.

[14]  W. Garvey,et al.  Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: Stability of metabolic health status in adults , 2016, Obesity.

[15]  Y. Ahn,et al.  Geographical difference in the prevalence of isolated systolic hypertension in middle-aged men and women in Korea: the Korean Health and Genome Study , 2005, Journal of Human Hypertension.

[16]  Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents , 1993, The Lancet.

[17]  E. Bonora,et al.  Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. , 1989, The New England journal of medicine.

[18]  G. Reaven,et al.  Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. , 1999, Metabolism: clinical and experimental.

[19]  G. Reaven,et al.  Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. , 1992, American journal of hypertension.

[20]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[21]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[22]  G. Reaven,et al.  Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. , 2000, Diabetes care.

[23]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[24]  E. Ferrannini,et al.  Insulin resistance in essential hypertension. , 1987, The New England journal of medicine.

[25]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[26]  C. Berne,et al.  Insulin resistance is a characteristic feature of primary hypertension independent of obesity. , 1990, Metabolism: clinical and experimental.

[27]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, Journal of the American Medical Association (JAMA).

[28]  C. Lamendola,et al.  Insulin resistance and cardiovascular disease risk factors in subjects with prehypertension , 2011, Diabetes & vascular disease research.

[29]  G. Reaven Relationships Among Insulin Resistance, Type 2 Diabetes, Essential Hypertension, and Cardiovascular Disease: Similarities and Differences , 2011, Journal of clinical hypertension.

[30]  R. Krauss,et al.  Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? , 2005, The American journal of cardiology.

[31]  C. Lamendola,et al.  Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. , 2009, American journal of hypertension.

[32]  G. Reaven Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[33]  P. Zimmet,et al.  Diagnosis and classification of diabetes mellitus , 2002 .

[34]  J. Viikari,et al.  The role of insulin in clustering of serum lipids and blood pressure in children and adolescents , 1995, Diabetologia.